ライフサイエンスコーパス: odds

1 p within 7 days were associated with a lower odds.

2 ndex, and prior amelanotic melanoma increase odds for development of amelanotic melanoma.

3 Thus, dual mimicry increases odds for mistranslation through evasion of one but not b

4 f days of clinical training was doubled, the odds for trainee supervision or repeated patient examina

5 7 linkage groups with a minimum logarithm of odds (LOD) of 8 and maximum recombination fraction of 0.

6 The odds of a reduction in the oral glucocorticoid dose were

7 dication were associated with lower adjusted odds of adherence for all four cost categories compared

8 is were independently associated with higher odds of an individual having epilepsy.

9 tivariable models, sclerostomy decreased the odds of an intraoperative or postoperative complication

10 The odds of being at risk for social-emotional competence we

11 was associated with a significantly reduced odds of both atopy and "any allergic condition" (adjuste

12 er adjustment for potential confounders, the odds of bowel intervention among patients treated laparo

13 tatus was associated with a 34% reduction in odds of CAD (odds ratio: 0.66; 95% confidence interval:

14 ratios (ORs) were calculated as the ratio of odds of cancer of two consecutive scores by logistic reg

15 127-variant score had a 2.49-fold increased odds of cardioembolic stroke (95% confidence interval, 1

16 Higher odds of daily smoking were observed in both cohorts for

17 with 1.06 (95% CI: 0.76, 1.50) times higher odds of death with greater upwind congestion within 150

18 used to identify outlier hospitals where the odds of delayed fixation were significantly higher or lo

19 ur of CIT was associated with a 5% increased odds of DGF (adjusted odds ratio: 1.05, 95% confidence i

20 The main outcome measure was the odds of discharge within 6 hours of presentation There w

21 es in antibiotic treatment administered, the odds of dying within 14 days were more than 4 times grea

22 inos (OR, 0.83; 95% CI, 0.81-0.86) had lower odds of filling antibiotic prescriptions.

23 CI = 1.04, 2.73) were associated with higher odds of GERD, while higher educational level (OR = 0.53,

24 1.30, 3.81) were positively associated with odds of GERD, while higher educational level (OR = 0.55,

25 = 0.33, 0.91) was associated with decreased odds of GERD.

26 %CI = 0.30, 0.94) were associated with lower odds of GERD.

27 catatonia signs were associated with greater odds of having delirium.

28 rved an 8% (95% CI: 6%, 11%) decrease in the odds of healthy aging per SD (0.062 m) increase in heigh

29 The odds of HF was higher in patients with a history of isch

30 NAI treatment was associated with decreased odds of hospital admission compared to no NAI treatment

31 rotein, lower waist circumference, and lower odds of hypertension and diabetes) and an unfavorable pr

32 ICU admission would more than double his/her odds of ICU admission if moving to a higher utilizing ho

33 in volume was associated with 73% increased odds of improving SMR over time [odds ratio (OR) 1.73; 9

34 ation was associated with a reduction in the odds of in-hospital death among patients aged 18-49 year

35 rom sweet food/beverages had a 23% increased odds of incident CMD after 5 years (95% CI: 1.02, 1.48)

36 nd higher body mass index (BMI)] and greater odds of large-vessel cerebral vascular disease or histor

37 s with symptomatic LV dysfunction had higher odds of lateral precordial T-wave inversions (odds ratio

38 In multivariable analyses, the odds of major morbidity/mortality were similar for early

39 We tested the hypothesis that the odds of malaria infection are lower in modern, improved

40 ancy was significantly associated with lower odds of mammography (odds ratio, 0.4; 95% CI, 0.3 to 0.8

41 hree or more antibiotic orders had a greater odds of milk allergy (Odds Ratio; 95% Confidence interva

42 Ligation was associated with lower odds of mortality (aOR, 0.09; 95% CI, 0.04-0.21).

43 o, 2.18; 95% CI, 1.90-2.51) but no increased odds of mortality (odd ratio, 1.07; 95% CI, .67-1.71).

44 0 mum and axial length by 1 mm increased the odds of ONHD presence by 1.5-fold (odds ratio [OR] = 1.5

45 as also significantly associated with higher odds of patient mortality, even after accounting for cli

46 There was a 28% increase in the odds of periodontitis for those with any ETS exposure co

47 The yearly increases in the odds of pretreatment drug resistance were 23% (95% CI 16

48 ng breakfast is associated with an increased odds of prevalent noncoronary and generalized atheroscle

49 The odds of PUM-antipsychotic exposure were also greater in

50 ith OAG enrolled in Medicaid had 198% higher odds of receiving no glaucoma testing compared with whit

51 eriod was associated with a 4.5-fold greater odds of receiving preferred beta-lactam therapy (95% con

52 The odds of recurrence (odds ratio, 1.13; 95% CI, .94-1.36)

53 By age 17 years, the odds of reporting clinical depression were more than sev

54 2; CI, 0.61-0.85) were associated with lower odds of reporting ever having received a dilated eye exa

55 symptom complexes have significantly higher odds of reporting poor self-rated health and impaired fu

56 I VFQ-25) scores were associated with higher odds of reporting use of eye care.

57 sting for farm type (broiler vs. layer), the odds of resistance (although not statistically significa

58 se of statistical techniques such as inverse odds of sampling weights, which under careful assumption

59 pon first meeting was associated with higher odds of SDCS (OR = 1.49, 95% CI: 1.21, 1.83) than was no

60 sexual partner(s) was associated with lower odds of SDCS (weekly: OR = 0.64, 95% CI: 0.47, 0.85; mon

61 We found no evidence of increased odds of serious infection in comparisons of the differen

62 lex CHD was associated with greater adjusted odds of serious ventricular arrhythmias (OR, 31.8; 95% C

63 history of cardiovascular disease but lower odds of small-vessel cerebral vascular disease.

64 r risk of subdural hematoma; and the highest odds of subdural hematoma was associated with combined u

65 ch unit decrease by day 7 from baseline, the odds of successful therapy doubled (odds ratio, 2.154; 9

66 ent Pf infection, but also with an increased odds of symptoms once infected.

67 ory of smoking were associated with a higher odds of the primary outcome, whereas treatment in a faci

68 g a priori hypotheses about variation in the odds of transmission given contact for free-ranging host

69 The odds of vCDR asymmetry >/=0.20 are 1.44 times higher per

70 ity was associated with unfavorable outcome (odds ratio %cerebral perfusion pressure < lower limit of

71 ple, greater grip strength (per 6 kg) had an odds ratio (95% CI) of 0.85 (0.73-1.00) for inpatient ad

72 both in patients who had GA (adjusted common odds ratio (cOR) 1.52, 95% CI 1.09-2.11, p=0.014) and in

73 Second, the median odds ratio (MOR) was calculated to quantify heterogeneit

74 e), only 1 (7.7%) eye developed new vessels, odds ratio (OR) 0.12 [95% confidence interval (CI): 0.01

75 anastomosis was associated with 30-day POM [odds ratio (OR) 1.71; 95% confidence interval (CI) 1.05-

76 % increased odds of improving SMR over time [odds ratio (OR) 1.73; 95% confidence interval (CI) 1.03-

77 r the intravenous group than the oral group [odds ratio (OR) 1.74, 95% confidence interval (CI) 1.05-

78 the highest quartile (4th) vs. lowest (1st), odds ratio (OR) = 0.66, 95% confidence interval (CI): 0.

79 ers (for fourth quartile vs. first quartile, odds ratio (OR) = 2.70, 95% confidence interval (CI): 1.

80 pecies (ROS) production, predisposes to SLE (odds ratio (OR) = 3.47 in Asians (Pmeta = 3.1 x 10(-104)

81 The overall odds ratio (OR) for ER visits for GI illness was 1.09 [9

82 Odds ratio (OR) for predicting poor outcome or standardi

83 ully-adjusted logistic regression model, the odds ratio (OR) per 10 unit change in renal elasticity f

84 onfidence interval: 1.12-2.55), rs4680 COMT (odds ratio (OR): 1.40; confidence interval: 1.04-1.87),

85 ng protein 15; rs4662344-T: P=1.9 x 10(-18), odds ratio (OR)=1.23) and COLQ (collagen-like tail subun

86 pared with individuals who did not have ASD (odds ratio (OR)=22.33, 95% confidence interval (CI): 21.

87 increased risk of borderline tumors (pooled odds ratio (pOR) = 1.32, 95% confidence interval (CI): 1

88 ratio 0.82, P = 0.001) and general surgeons (odds ratio 0.65, P = 0.002).

89 mortality only among early-career surgeons (odds ratio 0.82, P = 0.001) and general surgeons (odds r

90 vs 5.2 days; P = 0.015), more complications (odds ratio 1.36; 95% CI 1.04-1.78; adjusted rates 20% vs

91 frican ancestry-specific variant, rs1049549 (odds ratio 1.49 [95% CI 1.27-1.75]).

92 ere more likely to experience complications (odds ratio 1.51, P = 0.002) and longer hospital stays (+

93 (RPE) hemorrhage related to neovascular AMD (odds ratio 1.55 [95% confidence interval 1.31-1.84], P =

94 s 20% vs 16%; P = 0.023), more readmissions (odds ratio 1.57; 95% CI 1.08-2.29; adjusted rates 10% vs

95 2.62) for Crohn's disease and 1.3% and 0.7% (odds ratio 1.75; 1.44-2.13) for ulcerative colitis.

96 (26%) of 246 in the standard-of-care group (odds ratio 19.94, 95% CI 3.86-103.04, p=0.0004).

97 S vs. general population) was 0.8% and 0.3% (odds ratio 2.04; 1.59-2.62) for Crohn's disease and 1.3%

98 d with four (4%) of 105 controls (unadjusted odds ratio 2.4, 95% CI 0.8-7.3).

99 en similarly depressed at baseline (adjusted odds ratio 7.38, 1.73-31.50; p=0.0069).

100 nce = 4.1% [95% CI, -1.4% to 9.6%]; adjusted odds ratio = 0.61 [95% CI, 0.31 to 1.21]; P = .16).

101 tly associated with a higher risk of anemia (odds ratio = 1.14; 95% confidence interval: 1.01-1.28) a

102 escents whose parents separated (for ALSPAC, odds ratio = 1.46; for Pelotas Birth Cohort, odds ratio

103 y differed significantly between the groups, Odds ratio = 1.69.

104 odds ratio = 1.46; for Pelotas Birth Cohort, odds ratio = 1.98).

105 e history was the strongest predictor of OD (odds ratio = 14.8; 95% confidence interval: 12.7-17.2).

106 ssociated with the later development of JIA (odds ratio = 2.4, 95% confidence interval: 1.6, 3.6).

107 associated with a pattern of stable housing (odds ratio = 4.4, 95% confidence interval: 2.9, 6.8), an

108 = 9.52; P = 0.001), and high-dose steroids (odds ratio = 5.05; P = 0.01) retained significance in mu

109 entral nervous system (CNS) synucleinopathy (odds ratio = 7.1).

110 Rituximab (odds ratio = 9.52; P = 0.001), and high-dose steroids (o

111 independently associated with incident CVD (odds ratio [95% confidence interval]: 1.52 [1.07-2.16])

112 ] of 86 participants, respectively, adjusted odds ratio [aOR] 0.46, 95% CI 0.23-0.89; p=0.02).

113 risk HPV than did those not on ART (adjusted odds ratio [aOR] 0.83, 95% CI 0.70-0.99; I(2)=51%, adjus

114 Both CT HU (adjusted odds ratio [AOR] = 0.9989, interquartile odds ratio [IOR

115 y associated with renal impairment (adjusted odds ratio [aOR] = 2.1; 95% confidence interval [CI] = 1

116 attained minimum dietary diversity (adjusted odds ratio [aOR] for women 1.39, 95% CI 1.03-1.90; for c

117 Exposure to Alternaria (adjusted odds ratio [aOR], 1.07; 95% CI, 1.03-1.11), Leptosphaeri

118 se with resolved or current asthma (adjusted odds ratio [aOR], 1.9 [95% CI, 1.1-1.3] and 1.7 [95% CI,

119 h recent antecedent antibiotic use (adjusted odds ratio [aOR], 4.17; 95% confidence interval [CI], 1.

120 ted odds ratio [AOR] = 0.9989, interquartile odds ratio [IOR] = 0.4206) and BV/TV (AOR= 0.8096, IOR =

121 ast cancer risk overall (interquartile range odds ratio [IQ-OR], 1.37; 95% CI, 1.14 to 1.66; mC, 0.55

122 ated with a decreased alloimmunization risk (odds ratio [OR] 0.26, 95% confidence [CI] 0.11-0.64).

123 ess often parasitemic compared to AA adults (odds ratio [OR] 0.50 95% confidence interval [CI] 0.31-0

124 primary outcome were short disease duration (odds ratio [OR] 0.64, 95% CI 0.41-0.997 per year; p=0.04

125 ) included longer total duration of uveitis (odds ratio [OR] 1.13, P < .001), bilateral uveitis (OR 3

126 ntion clusters than in the control clusters (odds ratio [OR] 1.31, 95% CI 1.11-1.53).

127 reased tuberculosis diagnosis by microscopy (odds ratio [OR] 1.6, 95% CI 1.3-1.9, p<0.0001) or cultur

128 combined minor allele frequency [MAF] 0.22%; odds ratio [OR] 2.02; 95% CI 0.73-5.60; P = 0.18).

129 e blood pressure-lowering medicine (adjusted odds ratio [OR] 2.23, 95% CI 1.59-3.12); p<0.0001), comb

130 , 2.2% [1 of 45] vs no-LD, 26.2% [11 of 42]; odds ratio [OR] = 0.062; confidence interval [CI], 0.011

131 rative or postoperative complication by 80% (odds ratio [OR] = 0.2, 95% confidence interval [CI] = 0.

132 pendicitis were longer duration of symptoms (odds ratio [OR] = 1.46, P < .0001), increased maximum di

133 eased the odds of ONHD presence by 1.5-fold (odds ratio [OR] = 1.56 [confidence interval (CI), 1.22-2

134 ecurely attached to their primary caregiver (odds ratio [OR] = 1.7, p = 0.029, 95% CI [1.06, 2.76], d

135 redictive value were coma (31% had seizures; odds ratio [OR] = 1.8, p < 0.01) and history of seizures

136 s were less likely to report skin clearance (odds ratio [OR], 0.20; 95% CI, 0.07-0.55) and more likel

137 ith reductions in injurious falls: exercise (odds ratio [OR], 0.51 [95% CI, 0.33 to 0.79]; absolute r

138 likely to be adherent in both the tamoxifen (odds ratio [OR], 0.57; 95% CI, 0.37 to 0.86; P = .007) a

139 showed that isoniazid regimens of 6 months (odds ratio [OR], 0.65 [95% credible interval {CrI}, 0.50

140 nt antibiotics had lower 30-day ACS-related (odds ratio [OR], 0.71; 95% CI, 0.50-1.00) and all-cause

141 etween TRT and overall prostate cancer risk (odds ratio [OR], 1.03; 95% CI, 0.90 to 1.17).

142 re was independently associated with cancer (odds ratio [OR], 1.08 per procedure; 95% CI, 1.04-1.13).

143 44 times higher per 10-year increase in age (odds ratio [OR], 1.44; 95% confidence interval [CI], 1.2

144 with firearm violence in the validation set (odds ratio [OR], 1.47 [95% CI, 1.23 to 1.79]); this asso

145 ared with unexposed offspring (preterm birth odds ratio [OR], 1.47 [95% CI, 1.40-1.55]; small for ges

146 d with higher NAFLD activity score (adjusted odds ratio [OR], 1.644; P = 0.021), whereas elevated cre

147 non-Indigenous Australians, increasing age (odds ratio [OR], 1.72 per decade) and having not had an

148 al FS at 1 year post-HT: >/=18 years of age (odds ratio [OR], 1.8; 95% confidence interval [CI], 1.2-

149 n midlife was associated with elevated SUVR (odds ratio [OR], 2.06; 95% CI, 1.16-3.65).

150 nonsignificant impact on hospital mortality (odds ratio [OR], 2.1; P = 0.1; OR, 5, P = 0.05, respecti

151 Asthma was solely associated with pattern 1 (odds ratio [OR], 3.3; 95% CI, 1.5-7.2), rhinitis with pa

152 ent eGFR improvement were the LdT treatment (odds ratio [OR], 3.97 (1.37-11.5), p = 0.01) and pre-tre

153 Parathyroid lesion size of 10 mm or less (odds ratio [OR], 4.37; 95% CI, 2.24-8.54), multigland di

154 Ischemic heart disease (odds ratio [OR], 7.21; P < 0.001) and greater age (OR, 1

155 ations compared to non-use (14.3% vs. 33.3%; odds ratio [OR]: 0.33, 95% confidence interval [CI]: 0.1

156 sociated negatively with cumulative smoking (odds ratio [OR]: 0.992; 95% CI 0.984-1.000 per pack-year

157 of incident back pain among female subjects (odds ratio [OR]: 1.75, 95% confidence interval [CI]: 1.0

158 nificantly protect against clinical malaria (odds ratio [OR]=0.95, 95% CI 0.68-1.32, p=0.745 for case

159 th a positive organizational safety climate (Odds Ratio [OR]=2.76, 95% Confidence Interval [CI] 1.51-

160 ortality occurred after perforation, with an odds ratio for 12-month mortality of 1.35 for perforatio

161 or forest service employees and hunters, the odds ratio for alpha-gal-sIgE positivity was 2.48 compar

162 ncidence of CKD in the fully adjusted model (odds ratio for fourth versus first quartile, 1.81; 95% c

163 f MAC use in the VHA increased 17% per year (odds ratio for increase, 1.17; 95% confidence interval,

164 month modified Rankin Scale scores: adjusted odds ratio for the fifth quintile versus first quintile,

165 ore was calculated by the natural log of the odds ratio multiplied by the number of risk alleles.

166 : 71%, 80%), respectively, with a diagnostic odds ratio of 8 (95% CI: 3, 18) and only fair interobser

167 irst-trimester average atmospheric pressure (odds ratio per 5-mbar increase = 1.06, 95% confidence in

168 epinephrine as initial vasopressor (adjusted odds ratio quartile 4 vs quartile 1, 2.1; 95% CI, 1.6-2.

169 re likely to have lactate measured (adjusted odds ratio quartile 4 vs quartile 1, 2.8; 95% CI, 2.1-3.

170 ated and subsequently combined into a pooled odds ratio using a random-effects model.

171 rs) to those who were not regular users, the odds ratio was 2.0 (95% confidence interval: 1.2, 3.4).

172 of sensitivity, specificity, and diagnostic odds ratio were calculated.

173 s in 2 independent cohorts (combined cohort: odds ratio, 0.06; 95% CI, 0.02-0.22; P = 2.17 x 10-7).

174 ated with a significant risk of FMT failure (odds ratio, 0.15; 95% confidence interval, .007-.40).

175 nt shows a trend toward a protective effect (odds ratio, 0.16; 95% CI, 0.0-1.3; P = .08).

176 ssociated with reduced mortality (P = 0.005; odds ratio, 0.204; 95% confidence interval, 0.066-0.624)

177 ssion compared to no NAI treatment (adjusted odds ratio, 0.24; 95% confidence interval, 0.20-0.30).

178 39) and a reduced risk in adjusted analyses (odds ratio, 0.41; 95% CI, 0.171 to 0.986; P = .046).

179 ignificant decrease in the risk of delirium (odds ratio, 0.47; 95% CI, 0.38-0.56).

180 y associated with lower odds of mammography (odds ratio, 0.4; 95% CI, 0.3 to 0.8 for </= 5-year life

181 patients treated with second-generation DES (odds ratio, 0.51; 95% confidence interval, 0.38-0.68; P<

182 ,507; p = 0.08; I, 53%; random effect model: odds ratio, 0.63; 95% CI, 0.37-1.06).

183 nt) versus 137 (0.99+/-1.79 points/patient) (odds ratio, 0.64; confidence interval, 0.39-1.03; P=0.06

184 e of asthma between 8 and 16 years (adjusted odds ratio, 0.67; 95% CI, 0.47-0.94).

185 d risk of hepatic steatosis in participants (odds ratio, 0.69; 95% CI= 0.55-0.93; P value: 2.7 x 10(-

186 wer risk of death and myocardial infarction (odds ratio, 0.76; 95% confidence interval, 0.61-0.94; P=

187 lacebo (145 [31.7%] vs 174 [37.6%]; adjusted odds ratio, 0.78; 95% CI, 0.59-1.02; P = .07).

188 2,112; p = 0.29; I, 25%; fixed effect model: odds ratio, 0.83; 95% CI, 0.58-1.17) or rate of intubati

189 ts were not associated with incident stroke (odds ratio, 0.84; 95% CI, 0.48-1.47 in blacks and odds r

190 roups (49.3% vs. 46.3%, adjunct vs. control; odds ratio, 0.89; 95% confidence interval, 0.46-1.74; P

191 77-1.13; I = 0.0%) or observational studies (odds ratio, 0.90; 95% CI, 0.54-1.51; I = 76.1%).

192 95% confidence interval [CI], -2.93 to 0.72; odds ratio, 0.90; 95% CI, 0.76 to 1.07; P<0.001 for noni

193 MI performance measures and MI-ERR (adjusted odds ratio, 0.94; 95% CI, 0.81-1.08, per 0.1-unit increa

194 completion of a bolus of intravenous fluids (odds ratio, 1.01 per hour; 95% CI, 0.99 to 1.02; P=0.21)

195 r time to the administration of antibiotics (odds ratio, 1.04 per hour; 95% CI, 1.03 to 1.06; P<0.001

196 higher risk-adjusted in-hospital mortality (odds ratio, 1.04 per hour; 95% confidence interval [CI],

197 ratio, 0.84; 95% CI, 0.48-1.47 in blacks and odds ratio, 1.06; 95% CI, 0.80-1.41 in whites).

198 95% CI, 1.02-1.06; p < 0.001) and mortality (odds ratio, 1.06; 95% CI, 1.04-1.08; p < 0.001).

199 for failure of standard retrieval technique (odds ratio, 1.08; 95% confidence interval, 1.05-1.10; P<

200 The odds of recurrence (odds ratio, 1.13; 95% CI, .94-1.36) were similar among p

201 the laboratory arm and 79.5% in the POC arm (odds ratio, 1.13; 95% confidence interval, 0.51-2.53; P

202 patients had a 15% higher hospital survival (odds ratio, 1.15; 95% CI, 1.09-1.22; p < 0.001).

203 lysis, no difference in mortality was found (odds ratio, 1.16; 95% CI, 0.89-1.50).

204 ociated with increased mortality (P = 0.003; odds ratio, 1.254; 95% confidence interval, 1.078-1.457)

205 ated polyposis and multiple serrated polyps (odds ratio, 1.35; 95% confidence interval [CI], 0.64-2.8

206 versus 38.0% (155/408) of transfer patients (odds ratio, 1.47; 95% confidence interval, 1.13-1.92; P=

207 highest category versus <limit of detection; odds ratio, 1.50; 95% confidence interval, 1.09-2.07), b

208 ation than white subjects in the ICS+ group (odds ratio, 1.58; 95% CI, 1.01-2.48; P = .046) but not i

209 0.001), and low institutional volume of BAV (odds ratio, 1.58; 95% confidence interval, 1.06-2.37; P=

210 ive outcome in propensity-adjusted analysis (odds ratio, 1.61; 95% confidence interval [CI], 1.13-2.2

211 over conventional treatment (adjusted common odds ratio, 1.68; 95% confidence interval [CI], 1.15 to

212 ted risk of death/MI was higher among women (odds ratio, 1.6; 95% CI, 1.1-2.4) and minorities (odds r

213 after adjustment for 16 covariates (adjusted odds ratio, 1.77; 95% CI, 1.17 to 2.68); death occurred

214 greater risk-adjusted in-hospital mortality (odds ratio, 1.89 [95% CI, 1.79-2.00]).

215 f 153 [29.4%] vs 38 of 201 [18.9%]; adjusted odds ratio, 1.8; 95% CI, 1.5-2.2).

216 ratio, 1.6; 95% CI, 1.1-2.4) and minorities (odds ratio, 1.9; 95% CI, 1.2-2.8) compared with white me

217 ng increased reliance on gait aids (adjusted odds ratio, 1.9; 95% CI, 1.4-2.6); no functional status

218 an-Failure Assessment score greater than 10 (odds ratio, 12.9 [95% CI, 1.2-140]; p = 0.04) and cumula

219 C ratio at 7 years was associated with ACOS (odds ratio, 16.3; 95% confidence interval, 4.7-55.9) and

220 ed fluid-therapy volume greater than 10.7 L (odds ratio, 16.8 [1.6-180]; p = 0.02) as independent pre

221 dds of lateral precordial T-wave inversions (odds ratio, 18.4; 95% confidence interval, 2.92-116.18;

222 s 43% with cannabidiol and 27% with placebo (odds ratio, 2.00; 95% CI, 0.93 to 4.30; P=0.08).

223 ine, the odds of successful therapy doubled (odds ratio, 2.154; 95% CI, 1.173-3.955).

224 interval, 2.25-5.36; P<0.001), coagulopathy (odds ratio, 2.19; 95% confidence interval, 1.51-3.18; P<

225 remained independently associated with STDR (odds ratio, 2.3; 95% confidence interval, 1.1-4.9; P = 0

226 djusted risk of MI was higher in minorities (odds ratio, 2.6; 95% CI, 1.4-4.8).

227 creased risk for delirium the following day (odds ratio, 2.83 [1.27-6.59]; p = 0.02).

228 gone a previous clinical breast examination (odds ratio, 2.92; 95% CI, 1.30-6.60; P = .01).

229 he ipilimumab arm had an objective response (odds ratio, 2.9; 95% CI, 1.5 to 5.5; P = .002).

230 saw the movie not containing guns (adjusted odds ratio, 22.3; 95% CI, 6.0-83.4; P < .001).

231 -en-Y hepaticojejunostomy (vs duct-to-duct) (odds ratio, 3.06; 95% confidence interval, 1.52-6.16; P

232 6-9.7) and a family history of sudden death (odds ratio, 3.2; 95% confidence interval, 1.1-9.4) were

233 1), need for left ventricular assist device (odds ratio, 3.48; 95% confidence interval, 2.25-5.36; P<

234 decrease in eGFR of >1 ml/min per 1.73 m(2) (odds ratio, 3.64; 95% confidence interval, 1.37 to 9.91)

235 as significantly higher in the CAV(+) group (odds ratio, 3.9; P=0.0317) than in the CAV(-) group.

236 Prior syncope (odds ratio, 4.0; 95% confidence interval, 1.6-9.7) and a

237 ility of nevus dermoscopic pattern (adjusted odds ratio, 4.24; 95% CI, 1.36-13.25; P = .01) were asso

238 of 283 [31.4%] vs 26 of 282 [9.2%]; adjusted odds ratio, 4.6; 95% CI, 1.5-14.7) and a greater proport

239 ith non-CP-CRE bacteremic patients (adjusted odds ratio, 4.92; 95% confidence interval, 1.01-24.81).

240 associated with a CAC score greater than 0 (odds ratio, 5.1; 95% CI, 4.1-6.3; P < .001).

241 x; intravenous iron use for anemia (adjusted odds ratio, 5.4 [95% confidence interval, 1.4-21.1]); ma

242 95% confidence interval, 4.7-55.9) and COPD (odds ratio, 5.76; 95% confidence interval, 1.9-17.4), bu

243 severe acute respiratory infection (adjusted odds ratio, 5.87; 95% CI, 4.02-8.56; p < 0.001).

244 of in-hospital death were cardiogenic shock (odds ratio, 6.01; 95% confidence interval, 4.19-8.61; P<

245 and HRP prevalence beyond traditional risk (odds ratio, 6.0; 95% confidence interval, 1.1-31.7; P=0.

246 ciated with an eGFR<60 ml/min per 1.73 m(2) (odds ratio, 6.85; 95% confidence interval, 1.34 to 46.20

247 alysis, baseline total nevus count (adjusted odds ratio, 9.08; 95% CI, 4.0-23.7; P < .001) and increa

248 ignificant increase in their late TTA group (odds ratio, 9.63; 95% CI, 1.08-86.17; P = .03).

249 10% was strongly associated with infections (odds ratio, 99).

250 ions in 30-day and 90-day mortality from EP (odds ratio, OR 0.51, 95% confidence interval, CI, 0.40-0

251 ociated with a 34% reduction in odds of CAD (odds ratio: 0.66; 95% confidence interval: 0.44 to 0.98;

252 idence interval: 0.84-1.37) and VNTR 7 DRD4 (odds ratio: 0.68; confidence interval: 0.47-1.00).

253 nce interval: 1.16-2.37) and VNTR 10 SLC6A3 (odds ratio: 0.74; confidence interval: 0.60-0.90), where

254 statistically significant: rs1947274 LPHN3 (odds ratio: 0.95; confidence interval: 0.71-1.26), rs566

255 ed with a 5% increased odds of DGF (adjusted odds ratio: 1.05, 95% confidence interval [CI], 1.02-1.0

256 dence interval: 0.71-1.26), rs5661665 LPHN3 (odds ratio: 1.07; confidence interval: 0.84-1.37) and VN

257 variable number tandem repeat (VNTR) 4 DRD4 (odds ratio: 1.66; confidence interval: 1.16-2.37) and VN

258 otide polymorphisms (SNPs) rs1800544 ADRA2A (odds ratio: 1.69; confidence interval: 1.12-2.55), rs468

259 fidence interval: 1.04-1.87), rs5569 SLC6A2 (odds ratio: 1.73; confidence interval: 1.26-2.37) and rs

260 dent CMR predictor of the combined endpoint (odds ratio: 2.73; 95% confidence interval: 1.2 to 5.9; p

261 interval: 1.26-2.37) and rs28386840 SLC6A2 (odds ratio: 2.93; confidence interval: 1.76-4.90), and,

262 ) of 170 in the historical comparison group (odds ratio: 4.0; 95% confidence interval: 2.08 to 7.7; p

263 ctor for indication for step-down treatment (Odds ratio; 0.19).

264 c orders had a greater odds of milk allergy (Odds Ratio; 95% Confidence interval) (1.78; 1.28-2.48),

265 f 0.94, specificity of 0.71 and a diagnostic odds-ratio of 36.8.

266 Adjusted odds ratios (AORs) and 95% CIs were calculated.

267 del was constructed to quantify the adjusted odds ratios (aORs) of the exposure to PM10 and the risks

268 n increased risk of bladder cancer [adjusted odds ratios (OR) = 3.90, 95% confidence interval (CI) =

269 ldren with higher than lower estradiol, with odds ratios (OR) for asthma ranging from 1.25 for PFOS (

270 The odds ratios (OR) of the prevalence of asymptomatic ICAS

271 tatus (single or multiple primary melanoma); odds ratios (ORs) and 95% CIs are reported.

272 We estimated odds ratios (ORs) and 95% confidence intervals (CIs) by

273 We calculated odds ratios (ORs) and 95% confidence intervals (CIs) usi

274 ssion analysis was used to estimate adjusted odds ratios (ORs) and 95% confidence intervals (CIs).

275 istic regression was used to obtain adjusted odds ratios (ORs) and adjusted rate differences with 95%

276 implant and patient level to obtain adjusted odds ratios (ORs) and to control possible confounding ef

277 ere pooled in meta-analyses and expressed as odds ratios (ORs) or beta-estimates with 95% confidence

278 stic regression models were used to estimate odds ratios (ORs) that were adjusted for comorbidity, ed

279 We calculated pooled odds ratios (ORs) using a random-effects model.

280 of dynamic contrast-enhanced (DCE) imaging, odds ratios (ORs) were calculated as the ratio of odds o

281 Adjusted odds ratios (ORs) were calculated for each cohort and in

282 Effect sizes were reported as odds ratios (ORs) with 95% CIs.

283 Odds ratios (ORs) with 95% confidence intervals (CIs) fo

284 th among patients aged 18-49 years (adjusted odds ratios [aOR] = 0.21; 95% confidence interval [CI],

285 Crude and adjusted odds ratios and corresponding 95% CIs were estimated for

286 The odds ratios for being PCR positive was 7.4 (95% confiden

287 The adjusted odds ratios for gastroschisis for a 4-point increase in

288 al health problems at baseline and estimated odds ratios for subsequent onset of maternal and child m

289 There were no significant differences in the odds ratios for treatment retention (1.32; 95% CI, 0.87-

290 previous cesarean deliveries, with adjusted odds ratios of 1.16 (95% CI, 0.98-1.37) for 1 cesarean d

291 The odds ratios of complicated appendicitis for late vs earl

292 Odds ratios were calculated for OSs, and periodontal par

293 Adjusted odds ratios were calculated using multivariable logistic

294 Study-specific odds ratios were estimated and subsequently combined int

295 tion of men to the analysis yielded the same odds ratios when correctly adjusting for confounding.

296 able ordinal logistic regression to estimate odds ratios.

297 most significant (heterogeneity logarithm of odds score = 3.38).

298 This proposal is at odds with 40 years of experiments, but involves the key

299 rain regions, a strategy that seems to be at odds with the notion of lateralized functions in cerebra

300 m and 1.02 (95% CI: 0.95, 1.10) times higher odds within 151-300 m.